Endometrial Adenofibroma in a Patient Receiving Toremifene : A Case Report
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
INTRODUCTION: Adenofibroma is a rare benign Müllerian mixed tumor composed of epithelial and mesenchymal cells. This tumor may occasionally be associatedwith toremifene therapy which is used as an adjuvant drug for breast cancer.
CASE PRESENTATION: We describe a case of a 55-year-old woman with adenofibroma of the endometrium. This patient was receiving toremifene after surgery andneoadjuvant chemotherapy for breast cancer. She underwent a total abdominal hysterectomy and bilateral salpingectomy. There was no evidence oftumor residual or recurrence at 32 months of MRI follow-up.
CONCLUSION: In conclusion, we report a rare case of endometrial adenofibroma in a patient receiving toremifene. It must be borne in mind that long-termtoremifene therapy may increase the frequency of endometrial neoplasms.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 2023 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
---|---|
Enthalten in: |
Current medical imaging - 20(2023) vom: 26., Seite e260423216211 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Li, Lu [VerfasserIn] |
---|
Links: |
---|
Themen: |
7NFE54O27T |
---|
Anmerkungen: |
Date Completed 15.11.2023 Date Revised 15.11.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.2174/1573405620666230426143620 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM356738434 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM356738434 | ||
003 | DE-627 | ||
005 | 20231226071114.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2174/1573405620666230426143620 |2 doi | |
028 | 5 | 2 | |a pubmed24n1189.xml |
035 | |a (DE-627)NLM356738434 | ||
035 | |a (NLM)37170977 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Li, Lu |e verfasserin |4 aut | |
245 | 1 | 0 | |a Endometrial Adenofibroma in a Patient Receiving Toremifene |b A Case Report |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 15.11.2023 | ||
500 | |a Date Revised 15.11.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
520 | |a INTRODUCTION: Adenofibroma is a rare benign Müllerian mixed tumor composed of epithelial and mesenchymal cells. This tumor may occasionally be associatedwith toremifene therapy which is used as an adjuvant drug for breast cancer | ||
520 | |a CASE PRESENTATION: We describe a case of a 55-year-old woman with adenofibroma of the endometrium. This patient was receiving toremifene after surgery andneoadjuvant chemotherapy for breast cancer. She underwent a total abdominal hysterectomy and bilateral salpingectomy. There was no evidence oftumor residual or recurrence at 32 months of MRI follow-up | ||
520 | |a CONCLUSION: In conclusion, we report a rare case of endometrial adenofibroma in a patient receiving toremifene. It must be borne in mind that long-termtoremifene therapy may increase the frequency of endometrial neoplasms | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a endometrial adenofibroma; breast cancer; toremifene; magnetic resonance image | |
650 | 7 | |a Toremifene |2 NLM | |
650 | 7 | |a 7NFE54O27T |2 NLM | |
700 | 1 | |a Liu, Gang |e verfasserin |4 aut | |
700 | 1 | |a Huang, Li-Zhao |e verfasserin |4 aut | |
700 | 1 | |a Li, Tao |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current medical imaging |d 2020 |g 20(2023) vom: 26., Seite e260423216211 |w (DE-627)NLM306935120 |x 1573-4056 |7 nnns |
773 | 1 | 8 | |g volume:20 |g year:2023 |g day:26 |g pages:e260423216211 |
856 | 4 | 0 | |u http://dx.doi.org/10.2174/1573405620666230426143620 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 20 |j 2023 |b 26 |h e260423216211 |